The Business Research Company’s 2026 market reports are designed to deliver research that is more actionable and strategically valuable. Key offerings include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Genomics Personalized Health Market Size Insights: Annual Growth Rate, Revenue Outlook And Forecast Drivers
The market for genomics personalized health has expanded significantly in recent years. Its size is expected to increase from $18.5 billion in 2025 to $21.46 billion in 2026, registering a compound annual growth rate (CAGR) of 16.0%. The growth observed in the past can be attributed to advancements in sequencing technologies, declining costs of genomic testing, the expansion of clinical genomics research, the growth of personalized medicine initiatives, and the increasing availability of bioinformatics tools.
The genomics personalized health market is projected for substantial expansion, reaching $36.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.2%. This anticipated growth during the forecast period stems from factors such as the greater uptake of population-scale genomics initiatives, increased capital allocation towards AI-powered diagnostics, the broadening scope of personalized therapeutics, the deeper incorporation of genomics into standard clinical practices, and a heightened emphasis on predictive healthcare frameworks. Key developments expected during this timeframe involve a rise in the deployment of genomic data analytics platforms, the expanding application of artificial intelligence for interpreting genetic variations, the extension of tailored treatment approaches, the increasing incorporation of genomics into preventive health strategies, and a stronger emphasis on precise diagnostic methods.
Request A Free Excerpt Of The Genomics Personalized Health Global Market Report 2026:
What Will Drive Genomics Personalized Health Market Growth Through 2030?
The increasing demand for individualized medicine is projected to stimulate the expansion of the genomics personalized health market moving forward. Personalized medicine, also known as precision medicine, is a healthcare strategy that customizes medical treatments and practices to suit the specific characteristics of each patient. The necessity for personalized medicine arises from a transition towards preventive healthcare, enhanced treatment outcomes, greater patient empowerment and engagement, economic advantages, and the increasing prevalence of chronic and complex illnesses. Genomics personalized health substantially advances personalized medicine by utilizing individual genetic information to customize medical care across the spectrum, from prevention and diagnosis to treatment and monitoring. For instance, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Consequently, the rising demand for personalized medicine is fueling the demand within the genomics personalized health market.
Genomics Personalized Health Market Segment Analysis Covering All Major Categories
The genomics personalized health market covered in this report is segmented –
1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing
2) By Technology: NGS Platforms, Microarray, Genetic Analyzers
3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing
2) By Infectious Disease Testing: Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling
3) By Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels
4) By Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests
5) By Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests
Major Trends Shaping The Future Of The Genomics Personalized Health Market
Leading companies within the genomics personalized health market are prioritizing the creation of advanced solutions, such as cloud-based software for the tertiary analysis of clinical next-generation sequencing (NGS) data, to secure a market advantage. Clinical next-generation sequencing (NGS) data is genetic information produced by sequencing technologies that enable comprehensive, high-throughput analysis of DNA or RNA samples in clinical environments. As an example, in March 2023, Illumina, a US-based biotechnology firm known for DNA sequencing and array-based technologies, introduced Connected Insights, a cloud-based software specifically for the tertiary analysis of clinical next-generation sequencing (NGS) data. This platform is designed to simplify data interpretation and reporting workflows, especially in oncology, and facilitates extensive genomic profiling. Connected Insights incorporates diverse external knowledge bases, allowing for accurate data analysis and boosting the effectiveness of precision care efforts.
Genomics Personalized Health Market Competitive Environment And Key Companies
Major companies operating in the genomics personalized health market are Illumina Inc., Quest Diagnostics, Exact Sciences Corporation, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics, Novogenia GmbH, Clear Labs
Access Expert Genomics Personalized Health Market Analysis In The Full Report:
Which Regions Are Covered In The Genomics Personalized Health Market Report?
North America was the largest region in the personalized health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
